1-3 of 3
Chiara Catania
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research

Fabio Conforti, Laura Pala, Tommaso De Pas, Emma Zattarin, Chiara Catania, Emilia Cocorocchio, Giovanna Rossi, Daniele Laszlo, Marco Colleoni, Alberto Zambelli, Gabriel N. Hortobagyi, Javier Cortes, Martine J. Piccart, Mitch Dowsett, Richard D. Gelber, Giuseppe Viale
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (6): 1093–1103.
https://doi.org/10.1158/1078-0432.CCR-23-1836
Published: 15 March 2024
View article titled, Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research
Open the PDF for Fine-Tuning Adjuvant Endocrine Therapy for Early-Stage Breast Cancer: An Expert Consensus on Open Issues for Future Research in another window
Journal Articles

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Fabio Conforti, Laura Pala, Eleonora Pagan, Vincenzo Bagnardi, Tommaso De Pas, Paola Queirolo, Elisabetta Pennacchioli, Chiara Catania, Emilia Cocorocchio, Pier Francesco Ferrucci, Maristella Saponara, Gianmarco Orsolini, Paola Zagami, Eleonora Nicoló, Filippo De Marinis, Giampaolo Tortora, Emilio Bria, Saverio Minucci, Hadine Joffe, Paolo Veronesi, Jennifer Wargo, Rachel Rosenthal, Charles Swanton, Alberto Mantovani, Richard D. Gelber, Giuseppe Viale, Aron Goldhirsch, Giuseppe Giaccone
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4311–4324.
https://doi.org/10.1158/1078-0432.CCR-21-0136
Published: 01 August 2021
View article titled, Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion
Open the PDF for Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion in another window
Includes: Supplementary data
Journal Articles

Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors

Vanesa Gregorc, Filippo G. De Braud, Tommaso M. De Pas, Roberto Scalamogna, Giovanni Citterio, Alessandra Milani, Sabrina Boselli, Chiara Catania, Giovanni Donadoni, Gilda Rossoni, Domenico Ghio, Gianluca Spitaleri, Cristina Ammannati, Scialini Colombi, Federico Caligaris-Cappio, Antonio Lambiase, Claudio Bordignon
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1964–1972.
https://doi.org/10.1158/1078-0432.CCR-10-1376
Published: 31 March 2011
View article titled, Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
Open the PDF for Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors in another window